Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP)

John Walker; Vijay Kasturi; Celeste Lebbe; Shahneen Kaur Sandhu; Giovanni Grignani; Meliessa G Hennessy; Steven Hildemann; Josh Reed; Subramanian Hariharan

Conference Proceedings

Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP)

John Walker, Vijay Kasturi, Celeste Lebbe, Shahneen Kaur Sandhu, Giovanni Grignani, Meliessa G Hennessy, Steven Hildemann, Josh Reed, Subramanian Hariharan

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2018

DOI: 10.1200/JCO.2018.36.15_suppl.9537

Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP)

University of Melbourne Researchers

Citation metrics

Keywords